Although DC maturation is activated by the NF-κB pathway, the increase in VEGF due to the hypoxic environment of the tumor reduces the number of mDCs by inhibiting DC maturation through inhibition of the NF-κB pathway and suppresses immunity [103,104,105]. The gene discussed is NFKB1; the disease is neoplasm.